At least five states have introduced bills restricting the use of controversial mRNA technology or gene therapies in livestock or demand full disclosure to consumers on product packaging.
The states considering legislation include North Dakota, Tennessee, Arizona, Idaho, and Missouri.
Idaho House Bill 154 would make it a misdemeanor offense for anyone who provides or administers a vaccine using mRNA technology “for use in an individual or any other mammal in this state.”
Arizona House Bill 2762 requires conspicuous labeling of all aquatic, livestock, or poultry products that received mRNA vaccines, and prohibits these products from being labeled as organic.
Tennessee House Bill 0099 amends an existing law to prohibit the manufacture or sale of livestock or meat that contains mRNA “vaccine of vaccines materials” without a conspicuous label that there are such ingredients in the product.
In North Dakota, state lawmakers filed SB2384, which seeks to ban the use of mRNA vaccines in humans and to introduce a penalty for anyone breaking the prohibition.
Missouri State Rep. Holly Jones, a Republican, is the lead sponsor of a bill requiring product labeling of all livestock meat containing “potential gene therapy products.
“We label everything around the world. We label non-GMO. We label GMO. We label grass-fed. We label no antibiotics used. We label manufactured in a plant that has nuts,” Jones said.
“We should label anything that has not been proven safe and effective. As we’ve seen with the COVID vaccines, they’re neither safe nor effective. Even the CDC has come out with that.”
While HB1169 does not mention mRNA by name, the proposed ban would include all “potential gene therapy products.”
The House Emerging Issues subcommittee will review an amended bill on April 19. Jones is a member of that committee.
The bill would require labeling of any product created to act as a potential gene therapy, or that could “otherwise possibly impact, alter, or introduce genetic material or a genetic change into the user of the product.”
It would include anyone exposed to the product or people “exposed to others who have used the product.”
With the passage of HB1169, the law would require livestock farmers and producers in Missouri to fully display on product packaging mRNA technology used in cows, pigs, and other livestock under the rule of informed consent.
Already In Development
“They would have to tell us if they begin using those things. As it is currently, almost all states do not,” Jones said.
Jones said she confirmed through multiple agricultural sources that mRNA programs for U.S. livestock are “in the works.”
“It is in the pipeline. Australia is already doing that.”
According to a statement from the Queensland government in Australia, scientists are working to develop an mRNA-related vaccine to combat the threat of Lumpy Skin Disease (LSD) in beef cattle with $1.5 million invested.
“A new mRNA vaccine would be a game changer as the live virus vaccines currently available overseas cannot be used in Australia,” said Mark Furner—the Minister for Agricultural Industry Development and Fisheries and Minister for Rural Communities—in the statement.
“Using existing vaccines here would result in us losing our disease-free status,” Furner added.
With mRNA technology, as in COVID-19 vaccines, the injections introduce a virus fragment into cells, teaching them how to produce a specific antibody against the disease.
The Veterinary Microbiology and Preventive Medicine Department at Iowa State University is developing an mRNA-based cattle vaccine for the bovine respiratory syncytial virus (RSV).
Untreated, RSV can lead to pneumonia in cows.
The federal grant program aims to develop a “novel mRNA system” that provides immune protection against RSV.
“We hypothesize that a [mRNA injection] delivered continuously by vaccine implant will lead to prolonged and robust cellular and antibody immunity,” according to a program summary in the U.S. Department of Agriculture’s Research, Education, and Economics Information System (REEIS).
“Here, we will optimize our vaccine further and then test for potential correlates of protection to examine for in eventually challenged cows.”
No Labeling of Foreign Meat
In 2016, the U.S. Congress removed a labeling law requiring the country of origin on meat products.
“That means we could take beef from Argentina, Australia, China—anywhere around the world—and this gets mixed in because we no longer have to label it as country of origin.
“That strikes an issue with me,” Jones told The Epoch Times.
The National Cattlemen’s Beef Association recently stated that “there are no current mRNA vaccines licenses for use in beef cattle in the United States.”
“Cattle farmers and ranchers vaccinate cattle to treat and prevent many diseases, but presently none of these vaccines include mRNA technology.”
In August 2022, mRNA vaccine research start-up Genvax Technologies received $6.5 million in grant funding through a coalition of private investors, including United Animal Health.
“The threat posed to producers and consumers by foreign animal diseases like African swine fever (ASF) and constantly mutating variants of swine influenza is extraordinary,” Joel Harris, CEO and co-founder of Genvax Technologies, said in a release published in PorkBusiness.com.
“The goal is to develop a vaccine that matches 100 percent to the specific strain when a disease outbreak occurs.”
While ASF is a viral disease that is almost always fatal in domestic and wild pigs, it does not threaten human health and can’t spread from pigs to people.
“It is not a food safety issue,” the USDA states on its website.
“ASF is found in countries around the world. More recently, it has spread to the Dominican Republic and Haiti. ASF has also spread through China, Mongolia, and Vietnam, as well as within parts of the European Union.
“It has never been found in the United States—and we want to keep it that way.”
The Animal Health Institute (AHI) reports that mRNA vaccines used in veterinary medicine are at least five to 10 years away from deployment.
“New vaccines that use mRNA technologies to control parasites could allow more effective vaccines that can be reliably produced. Parasite vaccines developed through traditional methods are often difficult to reliably manufacture for companies,” the AHI’s website says.
“As a result, only a handful of parasite vaccines are available in veterinary medicines. However, mRNA could allow for more reliable production as these can avoid the difficulties of traditional methods.”
Not All Harmful?
Jones, however, said her bill does not mean she considers all mRNA technology harmful.
“They’re using it in many different medical studies and clinical trials. We do a good job of covering up things that may or may not be the best for us.
“I would like to see is that informed consent for consumers. I will fight for that tooth and nail.”
“What we’re asking is tell us if you are a cattle rancher or a pig farmer—if you choose to go that route with vaccinations—people should have that awareness whether to purchase that meat or 100 percent organic.”
Jones said lobbyists accused her of creating fear among consumers and affecting the “bottom line.”
“That’s upsetting to me. I have a strong moral standing that everyone has a right to choose what they put in their bodies.”
Texas Cites Concerns
On April 3, Texas Agricultural Commissioner Sid Miller said his office is working on a “fact-based analysis” of the risks associated with mRNA technology in food and livestock.
“Since news of the development of mRNA vaccines and mRNA-related treatments for livestock came to the attention of the Texas Department of Agriculture (TDA), we have been working towards developing a fact and science-based assessment of the risks associated with this technology,” Miller said in a statement.
“Our analysis will include the clinical research, the structure of existing Texas law, and the public policy, economic, and production impact of the different policy prescriptions we may adopt.
“I aim to ensure that Texas agriculture remains safe, trusted, healthy, and wholly uninfected by dangerous or unproven technology.”
“I personally take this issue very seriously. No political hot takes. Just a well-reasoned and well-researched proposal based on a wide range of input from stakeholders, scientists, agriculturalists, and other experts.
“We are looking at this issue at TDA and will share your concerns.”
The Texas agriculture department’s communications director Reb Wayne said many Texans expressed their concerns regarding mRNA technology.
Wayne said the department’s goal is “a safe and abundant food supply.”
“Our work is in its initial stages, and Commissioner Miller wants to make sure that both the [agricultural] industry and the general public are dealing with the facts on mRNA,” Wayne told The Epoch Times.
Jones said the Missouri legislation is for businesses and people who “deserve to know” the effects of mRNA in food and other products.
“We want to make sure people not only have informed consent and transparency in their food supply, but that if something happens without their knowledge, there is a way to stand firm,” Jones said.
“This is spreading like wildfire. And rightfully so.”
Article cross-posted from our premium news partners at The Epoch Times.
Bypass Big Tech Censors
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.